Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Global assessment of protein turnover in recombinant antibody producing myeloma cells.

Yee JC, Jacob NM, Jayapal KP, Kok YJ, Philp R, Griffin TJ, Hu WS.

J Biotechnol. 2010 Aug 2;148(4):182-93. doi: 10.1016/j.jbiotec.2010.06.005. Epub 2010 Jun 9.

PMID:
20540971
[PubMed - indexed for MEDLINE]
2.

Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.

Dinnis DM, Stansfield SH, Schlatter S, Smales CM, Alete D, Birch JR, Racher AJ, Marshall CT, Nielsen LK, James DC.

Biotechnol Bioeng. 2006 Aug 5;94(5):830-41.

PMID:
16489627
[PubMed - indexed for MEDLINE]
3.

Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.

Stansfield SH, Allen EE, Dinnis DM, Racher AJ, Birch JR, James DC.

Biotechnol Bioeng. 2007 Jun 1;97(2):410-24.

PMID:
17115445
[PubMed - indexed for MEDLINE]
4.

Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.

Smales CM, Dinnis DM, Stansfield SH, Alete D, Sage EA, Birch JR, Racher AJ, Marshall CT, James DC.

Biotechnol Bioeng. 2004 Nov 20;88(4):474-88.

PMID:
15459912
[PubMed - indexed for MEDLINE]
5.

Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities.

Alete DE, Racher AJ, Birch JR, Stansfield SH, James DC, Smales CM.

Proteomics. 2005 Dec;5(18):4689-704.

PMID:
16247733
[PubMed - indexed for MEDLINE]
6.

Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.

Krampe B, Swiderek H, Al-Rubeai M.

Biotechnol Appl Biochem. 2008 Jul;50(Pt 3):133-41. doi: 10.1042/BA20070195.

PMID:
18302537
[PubMed - indexed for MEDLINE]
7.

Molecular portrait of high productivity in recombinant NS0 cells.

Seth G, Philp RJ, Lau A, Jiun KY, Yap M, Hu WS.

Biotechnol Bioeng. 2007 Jul 1;97(4):933-51.

PMID:
17149768
[PubMed - indexed for MEDLINE]
8.

Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions.

Ho Y, Varley J, Mantalaris A.

Biotechnol Prog. 2006 Nov-Dec;22(6):1560-9.

PMID:
17137302
[PubMed - indexed for MEDLINE]
9.

Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC.

Doherty MK, Hammond DE, Clague MJ, Gaskell SJ, Beynon RJ.

J Proteome Res. 2009 Jan;8(1):104-12. doi: 10.1021/pr800641v.

PMID:
18954100
[PubMed - indexed for MEDLINE]
10.

A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.

Khoo SH, Falciani F, Al-Rubeai M.

Biotechnol Appl Biochem. 2007 Jun;47(Pt 2):85-95.

PMID:
17223793
[PubMed - indexed for MEDLINE]
11.

Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment.

Kantardjieff A, Jacob NM, Yee JC, Epstein E, Kok YJ, Philp R, Betenbaugh M, Hu WS.

J Biotechnol. 2010 Jan 15;145(2):143-59. doi: 10.1016/j.jbiotec.2009.09.008. Epub 2009 Sep 19.

PMID:
19770009
[PubMed - indexed for MEDLINE]
12.

Multitagging proteomic strategy to estimate protein turnover rates in dynamic systems.

Jayapal KP, Sui S, Philp RJ, Kok YJ, Yap MG, Griffin TJ, Hu WS.

J Proteome Res. 2010 May 7;9(5):2087-97. doi: 10.1021/pr9007738.

PMID:
20184388
[PubMed - indexed for MEDLINE]
13.

Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.

Barnes LM, Bentley CM, Moy N, Dickson AJ.

Biotechnol Bioeng. 2007 Feb 1;96(2):337-48.

PMID:
17001634
[PubMed - indexed for MEDLINE]
14.

The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.

Wu MH, Dimopoulos G, Mantalaris A, Varley J.

Biotechnol Appl Biochem. 2004 Aug;40(Pt 1):41-6.

PMID:
15270706
[PubMed - indexed for MEDLINE]
15.

Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.

Zuckier LS, Chang CJ, Scharff MD, Morrison SL.

Cancer Res. 1998 Sep 1;58(17):3905-8.

PMID:
9731501
[PubMed - indexed for MEDLINE]
Free Article
16.

[Metabolic characteristics of GS-nS0 myeloma cells producing anti-CD25 monoclonal antibody in serum-free culture].

Zhao L, Fan L, Zhang X, Tan W.

Sheng Wu Gong Cheng Xue Bao. 2009 Jul;25(7):1069-76. Chinese.

PMID:
19835150
[PubMed - indexed for MEDLINE]
17.

Immunochemical study of a human myeloma IgG1 half molecule.

Seligmann M, Mihaesco E, Chevalier A, Miglierina R.

Ann Immunol (Paris). 1978 Oct-Dec;129 C(6):855-70.

PMID:
85430
[PubMed - indexed for MEDLINE]
18.

Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses.

Magnusson CG, Björnstedt M, Holmgren A.

Mol Immunol. 1997 Jul;34(10):709-17.

PMID:
9430198
[PubMed - indexed for MEDLINE]
19.

Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.

Spens E, Häggström L.

Biotechnol Prog. 2005 Jan-Feb;21(1):87-95.

PMID:
15903244
[PubMed - indexed for MEDLINE]
20.

Matching isotopic distributions from metabolically labeled samples.

McIlwain S, Page D, Huttlin EL, Sussman MR.

Bioinformatics. 2008 Jul 1;24(13):i339-47. doi: 10.1093/bioinformatics/btn190.

PMID:
18586733
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk